Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 50649
Gene Symbol: ARHGEF4
ARHGEF4
0.020 AlteredExpression disease BEFREE APC interacts with Asef and stimulates its activity, thereby regulating the actin cytoskeletal network, cell morphology, adhesion and migration. 17143298 2006
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.010 GeneticVariation disease BEFREE APC mutations were inversely related to BRAF mutations (P = 0.0003) and CIMP (P = 0.02) and directly related to p53 and Ki-ras mutations (P = 0.04). 17293392 2007
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE APC mutations were inversely related to BRAF mutations (P = 0.0003) and CIMP (P = 0.02) and directly related to p53 and Ki-ras mutations (P = 0.04). 17293392 2007
Entrez Id: 4595
Gene Symbol: MUTYH
MUTYH
0.100 GeneticVariation disease BEFREE APC and biallelic MUTYH mutations are responsible for the majority of AFAP families. 17489848 2007
Entrez Id: 50649
Gene Symbol: ARHGEF4
ARHGEF4
0.020 Biomarker disease BEFREE APC also binds to APC-stimulated guanine nucleotide exchange factor, the kinesin superfamily-associated protein 3, IQGAP1, microtubules, EB1, and discs large (DLG). 17572842 2007
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 Biomarker disease BEFREE APC has both nuclear localization signals and nuclear export signals in its molecule, suggesting its occasional nuclear localization and export of beta-catenin from the nucleus. 17572842 2007
Entrez Id: 5879
Gene Symbol: RAC1
RAC1
0.010 Biomarker disease BEFREE APC interacts with the Rac1-specific guanine-nucleotide exchange factor (GEF) Asef, which contains an APC-binding region (ABR) in addition to Dbl homology (DH), Pleckstrin (PH) and Src homology 3 (SH3) domains. 17599059 2007
Entrez Id: 3014
Gene Symbol: H2AX
H2AX
0.010 PosttranslationalModification disease BEFREE APC knockdown with siRNA decreased the rate of DNA DSB-induced S139 histone H2AX phosphorylation in cells expressing endogenous full-length APC, but not in colon cancer cells with its truncation mutants, whereas ectopic APC expression stimulated the H2AX phosphorylation regardless of the type of endogenous APC. 18454178 2008
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 Biomarker disease BEFREE APC-free beta-catenin stimulates the Wnt signaling pathway, leading to active transcription of target genes. 18632633 2008
Entrez Id: 4255
Gene Symbol: MGMT
MGMT
0.030 PosttranslationalModification disease BEFREE APC and MGMT promoter methylation data were consistent and reproducible throughout the dilutions and all three replicates in the methylated DNA dilution matrix and between two experiments in clinical samples. 19179456 2009
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation disease BEFREE APC or p53 gene mutation and microsatellite instability (MSI) were assessed in primary tumours (PT) by single-strand conformation polymorphism. 19183332 2010
Entrez Id: 324
Gene Symbol: APC
APC
0.100 GeneticVariation disease BEFREE APC(min/+) mice, carrying a nonsense mutation in the adenomatous polyposis coli (APC) gene, appear as a perfect model to study development or therapy of intestinal neoplasia. 21649465 2011
Entrez Id: 2950
Gene Symbol: GSTP1
GSTP1
0.060 Biomarker disease BEFREE APC and GSTP1 methylation ratios below the threshold (predicting no cancer) produced a NPV of 0.96 and 0.80, respectively. 22077694 2012
Entrez Id: 2308
Gene Symbol: FOXO1
FOXO1
0.020 GeneticVariation disease BEFREE APC I1307K mutations and forkhead box gene (FOXO1A): another piece of an interesting correlation. 22180177 2012
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 Biomarker disease BEFREE APC is best known for its role as a negative regulator of the Wnt/β -catenin pathway. 24200292 2014
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 Biomarker disease BEFREE APC participates in a multiprotein "destruction complex" that targets the proto-oncogene β-catenin for ubiquitin-mediated proteolysis; however, the mechanistic role of APC in the destruction complex remains unknown. 24931405 2014
Entrez Id: 442891
Gene Symbol: MIR135B
MIR135B
0.030 Biomarker disease BEFREE APC was proven to be a target of miR‑135b and forms a feedback loop with miR‑135b. 25571954 2015
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 Biomarker disease BEFREE APC is best known as a scaffold protein in the β-catenin destruction complex, whose activity is antagonized by canonical Wnt signaling. 26193883 2015
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 Biomarker disease BEFREE APC haploinsufficiency coupled with p53 loss sufficiently induces mucinous cystic neoplasms and invasive pancreatic carcinoma in mice. 26411367 2016
Entrez Id: 4595
Gene Symbol: MUTYH
MUTYH
0.100 AlteredExpression disease BEFREE APC and MUTYH mRNA expression levels were investigated by quantitative Real-Time PCR (qRT-PCR) analysis using TaqMan assay and by ASE assays using dHPLC-based primer extension. 26511139 2015
Entrez Id: 2237
Gene Symbol: FEN1
FEN1
0.010 AlteredExpression disease BEFREE APC and Fen1 expression and interaction is increased in breast tumors versus normal cells, APC interacts with and blocks Fen1 activity in Pol-β-directed LP-BER, and abrogation of LP-BER is linked with cigarette smoke condensate-induced transformation of normal breast epithelial cells. 27088617 2016
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 GeneticVariation disease BEFREE APC deletion deregulates β-catenin, leads to high Wnt tone, and disrupts Notch1 signaling and primary cilium maintenance necessary for radial progenitor functions. 28916710 2017
Entrez Id: 2099
Gene Symbol: ESR1
ESR1
0.010 Biomarker disease BEFREE PAC has been shown to be largely negative for estrogen receptor alpha (ER-alpha). 30701026 2018
Entrez Id: 406988
Gene Symbol: MIR205
MIR205
0.010 Biomarker disease BEFREE APC was found to be a validated target of miR-205 and down-regulated in pancreatic cancer. 31391772 2019
Entrez Id: 8658
Gene Symbol: TNKS
TNKS
0.040 Biomarker disease BEFREE APC truncating mutations in Middle Eastern Population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC To 5-FU chemotherapy. 31704613 2020